课题基金 / 基金详情

Brain Rehabilitation Research Center

Brain Rehabilitation Research Center
脑康复研究中心
批准号:
10534109
负责人:
PRODIP K. BOSE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-10-01 至 2024-09-30
关键词:
AchievementAffectAgeAnimal ModelAttentionAwardBenchmarkingBiological MarkersBrainBrain imagingBudgetsCaringChronicClinicalCognitionCognitiveCollaborationsDiagnosisDiseaseEmotionalEmotionsEquipmentEthnic OriginEtiologyFeedbackFloridaFrightFundingGaitGenderGoalsHealthHealth systemHealthcareHealthcare SystemsHospitalsHumanImpaired cognitionInflammatoryInstitutionInterdisciplinary StudyInterventionLeadershipLocomotor trainingLong-Term CareMeasurementMeasuresMemoryMemory impairmentMentorsMissionMotorNervous System TraumaNeurodegenerative DisordersNeurologicNeuronal PlasticityNeurosciencesOrganizational ModelsPathologicPathologyPerformancePersonal SatisfactionPost-Traumatic Stress DisordersProcessProtocols documentationPsychotherapyQuality of lifeRaceRecoveryRegimenRehabilitation therapyResearchResearch PersonnelResource SharingResourcesRodent ModelRoleScienceSelf EfficacyServicesStrategic PlanningStrokeStructureSurvivorsTestingTimeTrainingTraumatic Brain InjuryUniversitiesUpper ExtremityUpper limb movementVeteransWalkingcareercentral nervous system injurychronic strokeclinical practiceclinical translationcognitive recoverycomorbiditycomparative effectiveness trialcostcost effectivecost estimatedisabilityefficacy evaluationemotion regulationexecutive functionfallsfeasibility testingfunctional restorationgait rehabilitationgenetic varianthuman modelimprovedinnovationmotor recoverymultiple disabilitynervous system disorderneuralneural networkneurological rehabilitationneurophysiologynovelpersistent symptompost strokepre-clinicalprogram disseminationprogramsrehabilitation researchresponsesensory feedbackstroke interventionstroke survivorstroke therapy

项目摘要

项目成果

PRODIP K. BOSE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Mission of the Brain Rehabilitation Research Center (BRRC) is: Maximize recovery of cognitive, emotion, and motor function in Veterans affected by neurologic injury or disease by potentiating neural plasticity and neural network reorganization through the discovery of mechanisms and innovation of treatments. The BRRC is a 19-yr consortium with three major institutions: North Florida/South Georgia VA Health Care System, University of Florida (UF)/Shands Healthcare, and Brooks Rehabilitation Hospital. The BRRC supports > 28 investigators (14 PIs with VA-funded studies, 14 associate investigators, and additional collaborating investigators) and their teams. The BRRC supports a collaborative, interdisciplinary research team, providing extensive facilities and resources for sophisticated human performance and brain function measurement. Our planned research programs utilize specific neuroplastic mechanisms to recover cognitive, emotion, and motor function. First, in the Cognition Function Initiative, we are developing innovative treatment for impaired memory, executive function, and goal achievement in TBI survivors. Second, in the Emotion Function Initiative, we are establishing new brain neuromarkers for objective diagnosis of PTSD and prediction of psychotherapy response in the presence and absence of TBI. We are investigating the etiological, pathological and neurophysiological mechanisms of PTSD comorbid with TBI, identifying brain networks involved in the emotional consequences of PTSD/TBI, and testing novel interventions to aid in recovery of emotion regulation. Third, in the Motor Function Initiative, we are investigating brain activation mechanisms during walking and during upper limb movement, to elucidate pathology and identify more useful treatment targets for inducing motor recovery. We are developing and feasibility-testing a new brain neural feedback regimen (real time brain imaging) to improve upper limb function after stroke. We are testing several innovative gait training interventions for stroke survivors: combination of gait coordination and brain stimulation; backward walking training paradigm; enhancing sensory feedback during walking and testing emotional fear factors related to fall self-efficacy; and feasibility-testing a protocol for a comparative effectiveness trial, for long-term mobility and health for chronic stroke. Fourth, in the Rehabilitation Neuroscience Initiative (animal and human models), we are refining our preclinical rodent models of TBI and SCI that reflect clinical symptoms of chronic and persistent disabilities in human TBI/SCI. We are establishing reliable, quantitative, and clinically translatable measures for assessing chronic multiple disabilities and for illuminating the role of TBI in chronic human neurodegenerative disease. We are evaluating efficacy of combined interventions, such as locomotor training and CNS stimulation, to mitigate TBI-induced disabilities. In stroke and TBI separately, we are evaluating the impact of potential modifiers such as age, gender, race/ethnicity, and moderating biomarkers of gene variants, brain structure/function, and inflammatory processes on cognitive impairment. The BRRC has consistently achieved the benchmarks expected by the RR&D Service, as follows: * Thematically cohesive, neural plasticity research portfolio focused on RR&D high priority Veteran needs for those with neurological injury or disease. * Robust science dissemination program, including national leadership by BRRC investigators. * Active and successful capacity-building program, including support and mentoring across career stages. * Excellent funding leverage ratio of Core Center award. * Acquisition and stewardship of extensive facilities, equipment, and shared resources for investigators. * Successful organizational model with a track record of strongly supporting investigators, inclusive budget planning process, visionary strategic planning process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical evaluation of efficacy and safety of a new iron chelator therapy in chronic spinal cord injury
  • 批准号:
    10701817
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    PRODIP K. BOSE
  • 依托单位:
Preclinical evaluation of efficacy and safety of a new iron chelator therapy in chronic spinal cord injury
  • 批准号:
    10536492
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    PRODIP K. BOSE
  • 依托单位:
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model
  • 批准号:
    10524736
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    PRODIP K. BOSE
  • 依托单位:
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model
  • 批准号:
    10000779
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    PRODIP K. BOSE
  • 依托单位:
海外基金